World Sleep Industry ENCYCLOPEDIA

Sleep Research

6.3.1

1. Definition, scope, and boundaries

Sleep research is the scientific study of sleep, circadian rhythms, and their relationships with health, behavior, environments, and social conditions through testable questions and systematic methods. It includes basic mechanisms, translational studies, population epidemiology, clinical trials, real-world research, implementation science, qualitative inquiry, and evidence synthesis. What makes an activity research is not the device it uses, but whether its question, design, measurements, analysis, and conclusions form a transparent chain of evidence.

Units of study may include molecules, cells, animal models, individuals, households, workplaces, healthcare systems, or populations. Each level answers different questions. A laboratory mechanism does not automatically demonstrate an effect in daily life, an association does not by itself explain causation, and a short-term surrogate cannot replace a long-term outcome that matters to participants. Translation between levels should state its intermediate assumptions and uncertainty.

Sleep research is not the same as an individual's clinical sleep examination, routine care, market research, product usability testing, or a think-tank report. A clinical examination primarily serves diagnosis for a patient, while market research primarily serves a business decision. Their data become research evidence only when a question is defined in advance, research ethics are observed, and suitable methods are used. A study result is also not, by itself, regulatory authorization, clinical advice, or proof of a product claim.

2. Research questions, protocols, and governance

A study should begin with a clear question that identifies the target population, exposure or intervention, comparator, outcomes, and time horizon. Exploratory work should still say what it seeks and when exploration will stop. Primary and secondary questions and supportive and exploratory analyses should remain distinguishable so that aims are not rewritten after results are seen. Intervention studies should also define the effect to be estimated and how events such as discontinuation, crossover, or nonadherence will be handled.

Before key outcomes are collected or inspected, the protocol should fix the design, recruitment, measurements, sample-size rationale, analysis, missing-data approach, and safety oversight. Dated amendments should be retained. When applicable, a study should be entered in a public registry, a systematic-review protocol registered, and computational or experimental procedures preregistered. Deviations should disclose their reason, timing, impact, and corrective response rather than replacing the original plan with a retrospective story.

Governance should identify the sponsor, institution, principal investigator, statistical and data owners, ethics review, monitoring or independent oversight, funding, and conflicts of interest. A commercial funder may help frame a question but should not suppress analysis or publication of unfavorable findings. Multicenter studies also need common versions, training, calibration, a data dictionary, escalation routes, and defined access to source data.

3. Populations, recruitment, and ethical consent

Human research should undergo applicable independent ethics review before it begins, with participants' dignity, rights, safety, and welfare taking priority. Informed consent should explain in understandable language the purpose, procedures, burdens, foreseeable risks and benefits, alternatives, privacy, compensation, withdrawal, and later data use. Consent is not a one-time signature; it is an ongoing process when protocols change, new risks emerge, or follow-up continues over time.

Eligibility criteria should follow the question, and reasons for exclusion should be disclosed. Age, sex, ethnicity, disability, pregnancy, comorbidity, medication, shift work, caregiving, housing, and digital access may affect both sleep and the opportunity to participate. Excluding a group requires a scientific or safety rationale. When a sample does not represent the target population, the conclusion should be narrowed rather than using statistical adjustment to conceal structural selection bias.

Vulnerability, power relationships, and financial incentives require additional safeguards. Relevant groups may include children, people with cognitive or communication limitations, employees, students, patients, and people whose judgment is affected by sleep loss. Overnight studies should address transport, falls, drowsy driving, and emergency response. Withdrawal should not compromise routine services, and continued use of existing data or specimens should follow the consent, ethics decision, and applicable rules.

4. Sleep measurement, devices, and data quality

A measurement plan should convert concepts into auditable variables and distinguish sleep opportunity, time in bed, sleep-onset latency, wake after sleep onset, total sleep time, sleep efficiency, sleep stages, circadian phase, perceived quality, and daytime function. Each outcome needs a time window, unit, calculation, valid-record rule, and clinical or lived meaning. One composite score should not be treated as the entirety of sleep.

Sleep diaries, questionnaires, actigraphy, consumer wearables, polysomnography, biomarkers, and interviews have different error structures. Methods should match the question and report the device model, sensor placement, sampling and filtering, firmware and algorithm versions, scoring rules, scorer training, and blinding. Outputs from different devices or algorithms are not interchangeable merely because their field names match, and data from before and after an upgrade should not be pooled without explanation.

Quality control should address clock synchronization, time zones and daylight-saving changes, wear adherence, signal loss, artifacts, nights crossing calendar dates, repeated measurements, laboratory calibration, and manual edits. Polysomnography is an important reference for particular questions, not an absolute truth for every outcome; consumer devices generally do not replace clinical diagnosis. Validation should occur for the intended use, target population, and real setting and should report failed samples and the proportion that could not be interpreted.

5. Statistical analysis, bias, and causal limits

Sample size should match the primary question, anticipated effect, variability, clustering, attrition, and analysis model rather than merely reaching a nominal head count. Randomized trials should describe sequence generation, allocation concealment, blinding, and analysis sets. Observational studies should identify confounding, selection, measurement bias, and reverse causation in advance. Repeated nights, household or center clusters, and time-varying exposures require suitable models.

Analysis should report the magnitude, direction, precision, and practical meaning of an effect, not only whether a significance threshold was crossed. Multiple outcomes, subgroups, time points, and repeated looks at data increase chance findings and require prospective limits or suitable adjustment. Missingness should be quantified, explained, and related to outcomes, with models, imputation, or sensitivity analyses consistent with stated assumptions. Simply deleting failed records may systematically remove participants who sleep worse or are harder for a device to measure.

Causal language must match the design and its assumptions. Randomization can still be affected by attrition, crossover, nonadherence, and measurement error, while an observational association does not become an effect merely because several variables were adjusted. Subgroup findings need interaction tests and independent confirmation. Machine-learning models also need protection against data leakage and evaluation of calibration, discrimination, group differences, and performance in an independent, real workflow.

6. Data management, sharing, and reproducibility

A data-management plan should identify collection sources, identifiers, formats, quality rules, versions, access rights, backups, retention, destruction, and accountable roles. Raw or near-raw signals, derived variables, scored results, and manual changes should be traceable, while analysis code should fix software and dependency versions. Corrections should leave an audit trail rather than erasing mistakes by overwriting the original values.

Sleep data may reveal health status, daily routines, living patterns, location, work, and information about household members. Removing names does not automatically make data anonymous, and continuous time series may be especially reidentifiable. Sharing therefore requires risk assessment against consent, ethics, and law, using minimization, de-identification, controlled access, data-use agreements, or secure analysis environments as appropriate. Open science does not mean unconditional release of sensitive data.

Reproducibility depends on complete protocols, data dictionaries, processing pipelines, exclusion logs, code, and environment descriptions, as well as honest records of failures and uncertainty. When participant-level data cannot be released, researchers can share metadata, variable definitions, simulated data, code, and an access route. Independent replication, cross-device comparison, and multicenter validation should distinguish rerunning the same analysis, reproducing a finding in new data, and testing whether a conclusion generalizes.

7. Reporting, translation, and continuing oversight

Reports should use guidance suited to their design and completely describe recruitment, exclusions, participant flow, baseline characteristics, delivery of exposure or intervention, missingness, harms, and all prespecified outcomes. Randomized trials, observational studies, and systematic reviews require different checklists. A checklist improves transparency but cannot turn a weak design into strong evidence. Differences among the registry entry, protocol, statistical analysis plan, and final report should remain visible.

Interpretation should consider effect magnitude, confidence intervals, bias, measurement limitations, applicable populations, alternative explanations, and consistency with existing evidence. Negative and uncertain findings deserve dissemination; switching outcomes, selecting time windows, or showing only favorable subgroups must not manufacture certainty. A news release, figure, or abstract should not claim stronger causality, clinical importance, or universality than the full report supports.

Translation into guidelines, products, policy, or clinical workflows requires the totality of evidence, feasibility, equity, resources, participant values, and continuing safety surveillance. A single study is usually one part of an evidence chain. Performance and risk should be reassessed when algorithms, devices, care pathways, or settings change. The endpoint of good sleep research is not publication alone, but making its questions, methods, data limits, and consequences for decisions open to inspection, challenge, and improvement.